Assessing the appropriate use of laparoscopic surgery for hepatobiliary diseases

J. M. Molina-Linde; Juan Ramon Lacalle-Remigio; R. Villegas-Portero; D. Díaz-Gómez; L. Gómez-Bujedo; P. Parra-Membrives

doi:10.1007/s00534-009-0177-4

Assessing the appropriate use of laparoscopic surgery for hepatobiliary diseases

Journal of Hepato-Biliary-Pancreatic Surgery ◽

10.1007/s00534-009-0177-4 ◽

2009 ◽

Vol 16 (6) ◽

pp. 844-849

Author(s):

J. M. Molina-Linde ◽

Juan Ramon Lacalle-Remigio ◽

R. Villegas-Portero ◽

D. Díaz-Gómez ◽

L. Gómez-Bujedo ◽

...

Keyword(s):

Laparoscopic Surgery ◽

Appropriate Use ◽

Hepatobiliary Diseases

Download Full-text

The early results of Robotic surgeryin treating pancreatic and hepatobiliarydiseases at Binh Dan Hospital

Vietnam Journal of Endolaparoscopic Surgery ◽

10.51199/vjsel.2018.3.4 ◽

2018 ◽

Vol 8 (3) ◽

Author(s):

Văn Hùng Võ ◽

Keyword(s):

Laparoscopic Surgery ◽

Da Vinci ◽

Robotic System ◽

Current Status ◽

Robot Assisted ◽

Intraoperative Complication ◽

Case Series Study ◽

Da Vinci Robotic System ◽

Hepatobiliary Diseases ◽

Robot Assisted Surgery

Tóm tắt Đặt vấn đề: Phẫu thuật nội soi đã được áp dụng phổ biến trong bệnh lý gan mật tụy. Gần đây, phẫu thuật nội soi robot hỗ trợ là một tiến bộ mới của phẫu thuật ống mật chủ, túi ít xâm lấn, cải thiện những bất lợi của phẫu thuật nội soi thông thường. Mục tiêu của chúng tôi là chia sẻ những kinh nghiệm sớm trong việc sử dụng Robot trong phẫu thuật gan mật tụy cũng như cập nhật vấn đề thời sự này. Phương pháp nghiên cứu: Nghiên cứu mô tả hàng loạt ca: 18 trường hợp (TH) bệnh lý gan mật tụy được phẫu thuật tại Bệnh viện Bình Dân từ tháng 01/2017 đến 09/2018 sử dụng hệ thống Robot da Vinci. Kết quả: Trong 18 TH bệnh lý gan mật tụy: 6 TH ung thư gan, 2 TH u thân đuôi tụy, 5 TH cắt tá tụy, 1 TH túi mật, và 4 TH nang ống mật chủ. Phẫu thuật thành công 17 TH, có 1 TH nang ống mật chủ chuyển mổ mở. Không có biến chứng trong phẫu thuật liên quan đến Robot. Không có biến chứng nặng. Không có tử vong. Kết luận: Sử dụng phẫu thuật nội soi có robot hỗ trợ trong bệnh lý gan mật tụy an toàn và khả thi Abstract Introduction: Laparoscopic surgery has been widely used in treating the pancreatic and hepatobiliary diseases. Recently, robot - assisted surgery was introduced as a new advance of minimally invasive surgery, could improve the disadvantages of conventional laparoscopic surgery. Aim of this study is to share early experiences in using robots in pancreatic and hepatobiliary surgery, as well as to update on the current status of robot - assisted surgery. Material and Methods: A descriptive case series study: (18) eighteen cases of pancreatic and hepatobiliary diseases were performed at Binh Dan hospital from 01/2017 to 09/2018 using the da Vinci robotic system. Results: In 18 patients: 6 hepatectomies, 2 spleen-preserving distal pancreatectomies, 5 pancreatoduodenectomies, 1 cholecystectomy, and 4 choledochal cystic resections. 17 were performed successful by robot - assisted surgery, 1 case of choledochal cystic resection converted to open surgery. There was no intraoperative complication related to the use of the da Vinci robotic system. No serious complications. No death was in this series. Conclusion: Using of robot - assisted surgery in pancreatic and hepatobiliary diseases is safe and feasible. Keyword: Robot – assisted surgery, da Vinci Surgical System, hepatectomy, distal pancreatectomy, pancreatoduodenectomy, cholecystectomy, choledochal cystic resection.

Download Full-text

Fifth Edition: the New Standard

Guides Newsletter ◽

10.1001/amaguidesnewsletters.2000.novdec01 ◽

2000 ◽

Vol 5 (6) ◽

pp. 1-7

Author(s):

Christopher R. Brigham ◽

James B. Talmage ◽

Leon H. Ensalada

Keyword(s):

Musculoskeletal System ◽

Medical Information ◽

Objective Assessment ◽

Scientific Data ◽

Practical Application ◽

Fourth Edition ◽

Appropriate Use ◽

Medical Evaluation ◽

Single Set

Abstract The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Fifth Edition, is available and includes numerous changes that will affect both evaluators who and systems that use the AMA Guides. The Fifth Edition is nearly twice the size of its predecessor (613 pages vs 339 pages) and contains three additional chapters (the musculoskeletal system now is split into three chapters and the cardiovascular system into two). Table 1 shows how chapters in the Fifth Edition were reorganized from the Fourth Edition. In addition, each of the chapters is presented in a consistent format, as shown in Table 2. This article and subsequent issues of The Guides Newsletter will examine these changes, and the present discussion focuses on major revisions, particularly those in the first two chapters. (See Table 3 for a summary of the revisions to the musculoskeletal and pain chapters.) Chapter 1, Philosophy, Purpose, and Appropriate Use of the AMA Guides, emphasizes objective assessment necessitating a medical evaluation. Most impairment percentages in the Fifth Edition are unchanged from the Fourth because the majority of ratings currently are accepted, there is limited scientific data to support changes, and ratings should not be changed arbitrarily. Chapter 2, Practical Application of the AMA Guides, describes how to use the AMA Guides for consistent and reliable acquisition, analysis, communication, and utilization of medical information through a single set of standards.

Download Full-text